Testing the amyloid hypothesis of Alzheimer's disease in vivo

Sam Gandy

doi:10.1016/S1474-4422(10)70055-7

Testing the amyloid hypothesis of Alzheimer's disease in vivo

Research output: Contribution to journal › Letter › peer-review

13 Scopus citations

Original language	English
Pages (from-to)	333-335
Number of pages	3
Journal	The Lancet Neurology
Volume	9
Issue number	4
DOIs	https://doi.org/10.1016/S1474-4422(10)70055-7
State	Published - Apr 2010

Access to Document

10.1016/S1474-4422(10)70055-7

Cite this

@article{d95ac2e8b3864203b991ac208f6084cf,

title = "Testing the amyloid hypothesis of Alzheimer's disease in vivo",

author = "Sam Gandy",

note = "Funding Information: I have received grants from the Forest Research Institute and from Amicus Pharmaceuticals, and I am a consultant to Diagenic and a member of the safety monitoring committee for the Elan and Johnson and Johnson AAC-001 trial. Research in my laboratories includes work on latrepirdine, but I receive no financial support from Pfizer or Medivation.",

year = "2010",

month = apr,

doi = "10.1016/S1474-4422(10)70055-7",

language = "English",

volume = "9",

pages = "333--335",

journal = "The Lancet Neurology",

issn = "1474-4422",

publisher = "Elsevier Ltd.",

number = "4",

}

TY - JOUR

T1 - Testing the amyloid hypothesis of Alzheimer's disease in vivo

AU - Gandy, Sam

N1 - Funding Information: I have received grants from the Forest Research Institute and from Amicus Pharmaceuticals, and I am a consultant to Diagenic and a member of the safety monitoring committee for the Elan and Johnson and Johnson AAC-001 trial. Research in my laboratories includes work on latrepirdine, but I receive no financial support from Pfizer or Medivation.

PY - 2010/4

Y1 - 2010/4

UR - http://www.scopus.com/inward/record.url?scp=77949284775&partnerID=8YFLogxK

U2 - 10.1016/S1474-4422(10)70055-7

DO - 10.1016/S1474-4422(10)70055-7

M3 - Letter

C2 - 20189880

AN - SCOPUS:77949284775

SN - 1474-4422

VL - 9

SP - 333

EP - 335

JO - The Lancet Neurology

JF - The Lancet Neurology

IS - 4

ER -